Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Bos

Showing results (81-90 of 88) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 88 results.
Journal for Nurses in Professional Development|March 18, 2016
Pressure Ulcer Prevention: Where Practice and Education MeetBrenda S Bos, Tina M Wangen, Carl E Elbing, et al.
Experimental Hematology & Oncology|September 22, 2023
Modelling acquired resistance to DOT1L inhibition exhibits the adaptive potential of KMT2A-rearranged acute lymphoblastic leukemiaPauline Schneider, Nicholas T Crump, Susan T C J M Arentsen-Peters, et al.
Arthritis Research & Therapy|July 25, 2007
Identification of an altered peptide ligand based on the endogenously presented, rheumatoid arthritis-associated, human cartilage glycoprotein-39(263-275) epitope: an MHC anchor variant peptide for immune modulationAnnemieke M H Boots, Henk Hubers, Milou Kouwijzer, et al.
Clinical Cardiology|September 9, 2014
Unilateral and multilateral congenital coronary-pulmonary fistulas in adults: clinical presentation, diagnostic modalities, and management with a brief review of the literatureSalah A M Said, Rogier L G Nijhuis, Jeroen W Op den Akker, et al.
Chemmedchem|April 25, 2008
Conjugation of ATIII-binding pentasaccharides to extend the half-life of proteins: long-acting insulinMartin de Kort, Bas Gianotten, Jeffry A J Wisse, et al.
NAR Cancer|December 15, 2022
A convergent malignant phenotype in B-cell acute lymphoblastic leukemia involving the splicing factor SRRM1Adria Closa, Marina Reixachs-Solé, Antonio C Fuentes-Fayos, et al.
Molecular Cancer Therapeutics|August 11, 2018
Unraveling the Interaction between Carboxylesterase 1c and the Antibody-Drug Conjugate SYD985: Improved Translational PK/PD by Using Ces1c Knockout MiceRuud Ubink, Eef H C Dirksen, Myrthe Rouwette, et al.
American Heart Journal|May 22, 2012
Rationale and design of the PRAETORIAN trial: a Prospective, RAndomizEd comparison of subcuTaneOus and tRansvenous ImplANtable cardioverter-defibrillator therapyLouise R A Olde Nordkamp, Reinoud E Knops, Gust H Bardy, et al.
Pageof 9

Showing results (81-90 of 88) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 88 results.
Journal for Nurses in Professional Development|March 18, 2016
Pressure Ulcer Prevention: Where Practice and Education MeetBrenda S Bos, Tina M Wangen, Carl E Elbing, et al.
Experimental Hematology & Oncology|September 22, 2023
Modelling acquired resistance to DOT1L inhibition exhibits the adaptive potential of KMT2A-rearranged acute lymphoblastic leukemiaPauline Schneider, Nicholas T Crump, Susan T C J M Arentsen-Peters, et al.
Arthritis Research & Therapy|July 25, 2007
Identification of an altered peptide ligand based on the endogenously presented, rheumatoid arthritis-associated, human cartilage glycoprotein-39(263-275) epitope: an MHC anchor variant peptide for immune modulationAnnemieke M H Boots, Henk Hubers, Milou Kouwijzer, et al.
Clinical Cardiology|September 9, 2014
Unilateral and multilateral congenital coronary-pulmonary fistulas in adults: clinical presentation, diagnostic modalities, and management with a brief review of the literatureSalah A M Said, Rogier L G Nijhuis, Jeroen W Op den Akker, et al.
Chemmedchem|April 25, 2008
Conjugation of ATIII-binding pentasaccharides to extend the half-life of proteins: long-acting insulinMartin de Kort, Bas Gianotten, Jeffry A J Wisse, et al.
NAR Cancer|December 15, 2022
A convergent malignant phenotype in B-cell acute lymphoblastic leukemia involving the splicing factor SRRM1Adria Closa, Marina Reixachs-Solé, Antonio C Fuentes-Fayos, et al.
Molecular Cancer Therapeutics|August 11, 2018
Unraveling the Interaction between Carboxylesterase 1c and the Antibody-Drug Conjugate SYD985: Improved Translational PK/PD by Using Ces1c Knockout MiceRuud Ubink, Eef H C Dirksen, Myrthe Rouwette, et al.
American Heart Journal|May 22, 2012
Rationale and design of the PRAETORIAN trial: a Prospective, RAndomizEd comparison of subcuTaneOus and tRansvenous ImplANtable cardioverter-defibrillator therapyLouise R A Olde Nordkamp, Reinoud E Knops, Gust H Bardy, et al.
Pageof 9